Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Terns Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 79 | 103 | +24 |
| Shares | 53.2M | 57.7M | +4.50M (+8.5%) |
| Value | $630.2M | $505.0M | −$125.2M (−19.9%) |
New holders (41)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (17)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Perceptive Advisors LLC | 1,350,000 | $16.0M |
| Point72 Asset Management, L.P. | 629,098 | $7.45M |
| EAM Investors, LLC | 128,186 | $1.52M |
| Velan Capital Investment Management LP | 120,000 | $1.42M |
| Qube Research & Technologies Ltd | 50,951 | $603.3K |
| D. E. Shaw & Co., Inc. | 46,762 | $553.7K |
| Mirabella Financial Services LLP | 33,334 | $394.7K |
| Cubist Systematic Strategies, LLC | 20,356 | $241.0K |
| Jump Financial, LLC | 18,356 | $217.3K |
| Fred Alger Management, LLC | 16,276 | $192.7K |
| 683 Capital Management, LLC | 16,000 | $189.4K |
| LMR Partners LLP | 15,849 | $187.7K |
| Man Group plc | – | $164.2K |
| Point72 Middle East FZE | 5,084 | $60.2K |
| Dark Forest Capital Management LP | 3,852 | $45.6K |
| TCI Wealth Advisors, Inc. | 200 | $2.37K |
| Belpointe Asset Management LLC | 100 | $1.18K |